Sumatriptan and Mestinon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Mestinon (pyridostigmine bromide). Common drug interactions include nausea among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Mestinon. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Mestinon?

Mestinon has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 5,948 Mestinon users. Check the latest studies of Mestinon.



On Jul, 09, 2026

30 people who take Sumatriptan and Mestinon together, and have interactions are studied.

Sumatriptan and Mestinon drug interactions.

What are the common drug interactions of Sumatriptan and Mestinon, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Activated partial thromboplastin time prolonged
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. B-lymphocyte count decreased
  7. Blood albumin decreased
  8. Blood bilirubin increased
  9. Blood calcium decreased
  10. Blood creatine phosphokinase increased

male:

  1. Asthenia (weakness)
  2. Myalgia (muscle pain)
  3. Muscle spasms (muscle contraction)
  4. Prostatomegaly (enlargement of the prostate)
  5. Therapeutic response unexpected
  6. Urine flow decreased
  7. Vitamin b complex deficiency
  8. Vitamin b12 deficiency
  9. Vitamin d deficiency
  10. Pain

What are the common drug interactions of Sumatriptan and Mestinon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia (weakness)
  2. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  3. Myalgia (muscle pain)
  4. Pain
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  7. Blood electrolytes decreased
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Dizziness
  10. Dysstasia (difficulty in standing)

40-49:

  1. Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
  2. Pneumonia viral
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Chronic kidney disease
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Pain
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Vertigo
  10. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Concussion (short loss of normal brain function in response to a head injury)
  4. Craniocerebral injury (injury to cranium and brain)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Palpitations (feelings or sensations that your heart is pounding or racing)
  7. Post concussion syndrome
  8. Stress
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Abdominal pain

60+:

  1. Activated partial thromboplastin time prolonged
  2. Alanine aminotransferase increased
  3. Blood fibrinogen increased
  4. Blood magnesium increased
  5. Blood osmolarity increased
  6. Blood phosphorus increased
  7. Blood potassium increased
  8. Blood prolactin increased
  9. Blood thyroid stimulating hormone decreased
  10. Blood urea increased

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.67%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 16.67%
  3. Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 13.33%
  4. Pain: 4 people, 13.33%
  5. Thymoma (a tumour originating from the epithelial cells of the thymus): 3 people, 10.00%
  6. Stress And Anxiety: 3 people, 10.00%
  7. Asthma: 3 people, 10.00%
  8. Nausea (feeling of having an urge to vomit): 3 people, 10.00%
  9. Metastases To Pleura (cancer spreads to pleura): 3 people, 10.00%
  10. Depression: 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Mestinon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan and Mestinon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mestinon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mestinon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and pyridostigmine bromide (the active ingredients of Sumatriptan and Mestinon, respectively), and Sumatriptan and Mestinon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: